Curis
CRIS
#11125
Rank
โ‚น0.25 B
Marketcap
โ‚น106.50
Share price
-1.77%
Change (1 day)
-28.72%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): -โ‚น2,165

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น2,283. In 2025 the company made an earnings per share (EPS) of -โ‚น2,283 an increase over its 2024 EPS that were of -โ‚น13,490.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น2,165-5.18%
2025-โ‚น2,283-83.07%
2024-โ‚น13,490-22.15%
2023-โ‚น17,328-26.17%
2022-โ‚น23,46822.3%
2021-โ‚น19,189-25.37%
2020-โ‚น25,713-30.93%
2019-โ‚น37,227-2.02%
2018-โ‚น37,994
2016-โ‚น86,350-10%
2015-โ‚น95,945138.1%
2014-โ‚น40,29740%
2013-โ‚น28,783-25%
2012-โ‚น38,37866.67%
2011-โ‚น23,027

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.69-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น341.56-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น34.54-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น300.31-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น408.73-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น483.56-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น16.31-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA